# \[e-drug\] Draft Manuscript for Good Clinical Research Practice **URL:** \ **Category:** e-drug\ **Created:** [August 30, 2005, 2:58pm UTC](https://talk.edrugplus.org/t/e-drug-draft-manuscript-for-good-clinical-research-practice/23219 "2005-08-30T14:58:49Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Couper\_Mary\_R](https://avatars.discourse-cdn.com/v4/letter/c/cc9497/32.png) [@Couper\_Mary\_R](https://talk.edrugplus.org/u/Couper_Mary_R)\ **Post date:** [August 30, 2005, 2:58pm UTC](https://talk.edrugplus.org/t/e-drug-draft-manuscript-for-good-clinical-research-practice/23219/1 "2005-08-30T14:58:49Z")
E-DRUG: Draft Manuscript for Good Clinical Research Practice -------------------------------------------------------- A draft manuscript "Handbook for Good Clinical Research Practice (GCP): Guidance for implementation" is available at [http://www.who.int/medicines/](http://www.who.int/medicines/) in the "Latest" This text is as an adjunct to WHO's "Guidelines for good clinical practice (GCP) for trials on pharmaceutical products" (1995), and is intended to assist national regulatory authorities, sponsors, investigators and Ethics Committees in implementing GCP for industry-sponsored, government-sponsored, or investigator-initiated clinical research. It is an educational tool to facilitate the understanding and implementation of GCP. As part of the global consultation process in the development of this document WHO welcomes any comments on this draft. We should value your input before the end of September in order that we may keep to our time-frame of publishing this document before the end of the year. Dr M R Couper Medical Officer, Quality Assurance and Safety of Medicines Medicines Policy and Standards World Health Organization Tel: +41 2279 13643/12337 Email: couperm@who.int